1.
|
A JemalR SiegelE WardT MurrayJ XuMJ
ThunCancer statistics, 2007CA Cancer J
Clin574366200710.3322/canjclin.57.1.43
|
2.
|
PJ MesserschmittAN RettewRE BrookoverRM
GarciaPJ GettyEM GreenfieldSpecific tyrosine kinase inhibitors
regulate human osteosarcoma cells in vitroClin Orthop Relat
Res46621682175200810.1007/s11999-008-0338-918607665
|
3.
|
G BacciA LonghiM VersariM MercuriA
BriccoliP PicciPrognostic factors for osteosarcoma of the extremity
treated with neoadjuvant chemotherapy: 15-year experience in 789
patients treated at a single
institutionCancer10611541161200616421923
|
4.
|
A LonghiC ErraniM De PaolisM MercuriG
BacciPrimary bone osteosarcoma in the pediatric age: state of the
artCancer Treat
Rev32423436200610.1016/j.ctrv.2006.05.00516860938
|
5.
|
Y ZhangRX WeiXB ZhuL CaiW JinH
HuTanshinone IIA induces apoptosis and inhibits the proliferation,
migration and invasion of the osteosarcoma MG-63 cell line in
vitroAnticancer
Drugs23212219201210.1097/CAD.0b013e32834e559222126901
|
6.
|
E KobayashiFJ HornicekZ DuanMicroRNA
involvement in
osteosarcomaSarcoma2012359739201210.1155/2012/35973922550419
|
7.
|
RR LullaFF CostaJM BischofIdentification
of differentially expressed microRNAs in
osteosarcomaSarcoma2011732690201110.1155/2011/73269021789031
|
8.
|
A LujambioSW LoweThe microcosmos of
cancerNature482347355201210.1038/nature1088822337054
|
9.
|
V RottiersAM NäärMicroRNAs in metabolism
and metabolic disordersNat Rev Mol Cell
Biol13239250201210.1038/nrm331322436747
|
10.
|
W ZhangME DolanThe emerging role of
microRNAs in drug responsesCurr Opin Mol
Ther12695702201021154161
|
11.
|
L WangAL ObergYW AsmannGenome-wide
transcriptional profiling reveals microRNA-correlated genes and
biological processes in human lymphoblastoid cell linesPLoS
One11e5878200910.1371/journal.pone.000587819517021
|
12.
|
H ZhaoJ ShenL MedicoD WangCB AmbrosoneS
LiuA pilot study of circulating miRNAs as potential biomarkers of
early stage breast cancerPLoS
One5e13735201010.1371/journal.pone.001373521060830
|
13.
|
L GuoY LiuY BaiY SunF XiaoY GuoGene
expression profiling of drug-resistant small cell lung cancer cells
by combining microRNA and cDNA expression analysisEur J
Cancer4616921702201010.1016/j.ejca.2010.02.04320371173
|
14.
|
T VergoulisIS VlachosP AlexiouTarBase 6.0:
capturing the exponential growth of miRNA targets with experimental
supportNucleic Acids Res40Database
issueD222D229201210.1093/nar/gkr116122135297
|
15.
|
T XuY ZhuY XiongYY GeJP YunSM
ZhuangMicroRNA-195 suppresses tumorigenicity and regulates G1/S
transition of human hepatocellular carcinoma
cellsHepatology50113121200910.1002/hep.2291919441017
|
16.
|
W YeQ LvCK WongThe effect of central loops
in miRNA:MRE duplexes on the efficiency of miRNA-mediated gene
regulationPLoS
One3e1719200810.1371/journal.pone.000171918320040
|
17.
|
L LiuL ChenY XuR LiX DumicroRNA-195
promotes apoptosis and suppresses tumorigenicity of human
colorectal cancer cellsBiochem Biophys Res
Commun400236240201010.1016/j.bbrc.2010.08.04620727858
|
18.
|
Y MurakamiT YasudaK SaigoComprehensive
analysis of microRNA expression patterns in hepatocellular
carcinoma and non-tumorous
tissuesOncogene2525372345200610.1038/sj.onc.120928316331254
|
19.
|
Y LinJ WuH ChenCyclin-dependent kinase 4
is a novel target in micoRNA-195-mediated cell cycle arrest in
bladder cancer cellsFEBS
Lett586442447201210.1016/j.febslet.2012.01.02722289176
|
20.
|
C OneyamaJ IkedaD OkuzakiMicroRNA-mediated
downregulation of mTOR/FGFR3 controls tumor growth induced by
Src-related oncogenic
pathwaysOncogene3034893501201110.1038/onc.2011.6321383697
|
21.
|
M HafnerM LandthalerL
BurgerTranscriptome-wide identification of RNA-binding protein and
microRNA target sites by
PAR-CLIPCell141129141201010.1016/j.cell.2010.03.00920371350
|
22.
|
M DoghmanA El WakilB CardinaudRegulation
of insulin-like growth factor-mammalian target of rapamycin
signaling by microRNA in childhood adrenocortical tumorsCancer
Res7046664675201010.1158/0008-5472.CAN-09-397020484036
|
23.
|
LM GuoY PuZ HanMicroRNA-9 inhibits ovarian
cancer cell growth through regulation of NF-kappaB1FEBS
J27655375546200910.1111/j.1742-4658.2009.07237.x19702828
|
24.
|
L MaJ YoungH PrabhalamiR-9, a
MYC/MYCN-activated microRNA, regulates E-cadherin and cancer
metastasisNat Cell Biol12247256201020173740
|
25.
|
A GrimsonKK FarhWK JohnstonP
Garrett-EngeleLP LimDP BartelMicroRNA targeting specificity in
mammals: determinants beyond seed pairingMol
Cell2791105200710.1016/j.molcel.2007.06.01717612493
|
26.
|
ST LiffersJB MundingM VogtMicroRNA-148a is
down-regulated in human pancreatic ductal adenocarcinomas and
regulates cell survival by targeting CDC25BLab
Invest9114721479201110.1038/labinvest.2011.9921709669
|
27.
|
B ZhengL LiangC WangMicroRNA-148a
suppresses tumor cell invasion and metastasis by downregulating
ROCK1 in gastric cancerClin Cancer
Res1775747583201110.1158/1078-0432.CCR-11-171421994419
|
28.
|
R CuestaA Martínez-SánchezF
GebauermiR-181a regulates cap-dependent translation of p27(kip1)
mRNA in myeloid cellsMol Cell
Biol2928412851200910.1128/MCB.01971-0819273599
|
29.
|
W ZhuX ShanT WangY ShuP LiumiR-181b
modulates multidrug resistance by targeting BCL2 in human cancer
cell linesInt J Cancer12725202529201010.1002/ijc.2526020162574
|
30.
|
KH ShinSD BaeHS HongRH KimMK KangNH
ParkmiR-181a shows tumor suppressive effect against oral squamous
cell carcinoma cells by downregulating K-rasBiochem Biophys Res
Commun404896902201110.1016/j.bbrc.2010.12.05521167132
|
31.
|
J JiT YamashitaA BudhuIdentification of
microRNA-181 by genome- wide screening as a critical player in
EpCAM-positive hepatic cancer stem
cellsHepatology50472480200910.1002/hep.2298919585654
|
32.
|
X ZhangY NieY DuJ CaoB ShenY
LiMicroRNA-181a promotes gastric cancer by negatively regulating
tumor suppressor KLF6Tumour
Biol33921928201210.1007/s13277-012-0414-322581522
|
33.
|
T ChiyomaruH EnokidaS TataranomiR-145 and
miR-133a function as tumour suppressors and directly regulate FSCN1
expression in bladder cancerBr J
Cancer102883891201010.1038/sj.bjc.660557020160723
|
34.
|
M KanoN SekiN KikkawamiR-145, miR-133a and
miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal
squamous cell carcinomaInt J
Cancer12728042814201010.1002/ijc.2528421351259
|
35.
|
J ZhangQ SunZ ZhangS GeZG HanWT ChenLoss
of microRNA- 143/145 disturbs cellular growth and apoptosis of
human epithelial cancers by impairing the MDM2-p53 feedback
loopOncogene2810381046201222330136
|
36.
|
Y AkaoY NakagawaT NaoeMicroRNA-143 and
-145 in colon cancerDNA Cell
Biol26311320200710.1089/dna.2006.055017504027
|
37.
|
M OsakiF TakeshitaY SugimotoMicroRNA-143
regulates human osteosarcoma metastasis by regulating matrix
metalloprotease-13 expressionMol
Ther1911231130201110.1038/mt.2011.5321427707
|
38.
|
PM BorralhoBT KrenRE CastroIB da SilvaCJ
SteerCM RodriguesMicroRNA-143 reduces viability and increases
sensitivity to 5-fluorouracil in HCT116 human colorectal cancer
cellsFEBS
J27666896700200910.1111/j.1742-4658.2009.07383.x19843160
|
39.
|
X ChenX GuoH ZhangRole of miR-143
targeting KRAS in colorectal
tumorigenesisOncogene2813851392200910.1038/onc.2008.47419137007
|
40.
|
H HeynM EngelmannS SchreekMicroRNA miR-335
is crucial for the BRCA1 regulatory cascade in breast cancer
developmentInt J Cancer12927972806201110.1002/ijc.2596221618216
|
41.
|
SF TavazoieC AlarcónT OskarssonEndogenous
human microRNAs that suppress breast cancer
metastasisNature451147152200810.1038/nature0648718185580
|
42.
|
YN LeeS BrandalP NoelKIT signaling
regulates MITF expression through miRNAs in normal and malignant
mast cell
proliferationBlood11736293640201110.1182/blood-2010-07-29354821273305
|
43.
|
SK PatnaikE KannistoS
YendamuriOverexpression of microRNA miR-30a or miR-191 in A549 lung
cancer or BEAS-2B normal lung cell lines does not alter
phenotypePLoS One5e9219201010.1371/journal.pone.000921920169152
|
44.
|
J KimDM CoffeyCJ CreightonZ YuSM HawkinsMM
MatzukHigh-grade serous ovarian cancer arises from fallopian tube
in a mouse modelProc Natl Acad Sci
USA10939213926201210.1073/pnas.111713510922331912
|
45.
|
P Puerta-GilR García-BaqueroAY JiamiR-143,
miR-222 and miR-452 are useful as tumor stratification and
noninvasive diagnostic biomarkers for bladder cancerAm J
Pathol18018081815201210.1016/j.ajpath.2012.01.03422426337
|
46.
|
MA CortezJW WelshGA CalinCirculating
microRNAs as noninvasive biomarkers in breast cancerRecent Results
Cancer Res195151161201210.1007/978-3-642-28160-0_1322527502
|
47.
|
JT MendellEN OlsonMicroRNAs in stress
signaling and human
diseaseCell14811721187201210.1016/j.cell.2012.02.00522424228
|
48.
|
E Varkonyi-GasicRP HellensQuantitative
stem-loop RT-PCR for detection of microRNAsMethods Mol
Biol744145157201110.1007/978-1-61779-123-9_1021533691
|
49.
|
T SaitoP SaetromMicroRNAs - targeting and
target predictionN
Biotechnol27243249201010.1016/j.nbt.2010.02.01620219708
|
50.
|
ME PeterTargeting of mRNAs by multiple
miRNAs: the next
stepOncogene2921612164201010.1038/onc.2010.5920190803
|
51.
|
S WuS HuangJ DingMultiple microRNAs
modulate p21Cip1/Waf1 expression by directly targeting its 3′
untranslated regionOncogene2923022308201020190813
|
52.
|
DW ThomsonCP BrackenGJ GoodallExperimental
strategies for microRNA target identificationNucleic Acids
Res3968456853201110.1093/nar/gkr33021652644
|
53.
|
TA FaraziJI SpitzerP MorozovT TuschlmiRNAs
in human cancerJ Pathol223102115201110.1002/path.2806
|
54.
|
SK ShenoudaSK AlahariMicroRNA function in
cancer: oncogene or a tumor suppressor?Cancer Metastasis
Rev28369378200910.1007/s10555-009-9188-520012925
|
55.
|
H ZhangX CaiY WangH TangD TongF
JimicroRNA-143, down-regulated in osteosarcoma, promotes apoptosis
and suppresses tumorigenicity by targeting Bcl-2Oncol
Rep2413631369201020878132
|
56.
|
L FanQ WuX XingY WeiZ ShaoMicroRNA-145
targets vascular endothelial growth factor and inhibits invasion
and metastasis of osteosarcoma cellsActa Biochim Biophys Sin
(Shanghai)44407414201210.1093/abbs/gms01922472569
|
57.
|
D LiX LiuL LinMicroRNA-99a inhibits
hepatocellular carcinoma growth and correlates with prognosis of
patients with hepatocellular carcinomaJ Biol
Chem2863667736685201110.1074/jbc.M111.27056121878637
|
58.
|
D SunYS LeeA MalhotramiR-99 family of
MicroRNAs suppresses the expression of prostate-specific antigen
and prostate cancer cell proliferationCancer
Res7113131324201110.1158/0008-5472.CAN-10-103121212412
|
59.
|
DM ÖzataS CaramutaD Velázquez-FernándezThe
role of microRNA deregulation in the pathogenesis of adrenocortical
carcinomaEndocr Relat Cancer18643655201121859927
|
60.
|
R MahnLC HeukampS RogenhoferA von
RueckerSC MüllerJ EllingerCirculating microRNAs (miRNA) in serum of
patients with prostate
cancerUrology771265.e916201110.1016/j.urology.2011.01.02021539977
|
61.
|
WC ChoEpigenetic alteration of microRNAs
in feces of colorectal cancer and its clinical significanceExpert
Rev Mol Diagn11691694201110.1586/erm.11.5721902530
|
62.
|
KB JonesZ SalahS Del MaremiRNA signatures
associate with pathogenesis and progression of osteosarcomaCancer
Res7218651877201210.1158/0008-5472.CAN-11-266322350417
|
63.
|
NM WhiteTT BaoJ GrigullmiRNA profiling for
clear cell renal cell carcinoma: biomarker discovery and
identification of potential controls and consequences of miRNA
dysregulationJ
Urol18610771083201110.1016/j.juro.2011.04.11021784468
|
64.
|
MM VickersJ BarI
Gorn-HondermannStage-dependent differential expression of microRNAs
in colorectal cancer: potential role as markers of metastatic
diseaseClin Exp
Metastasis29123132201210.1007/s10585-011-9435-322120473
|
65.
|
M ShuY ZhouW ZhuMicroRNA 335 is required
for differentiation of malignant glioma cells induced by activation
of cAMP/protein kinase A pathwayMol
Pharmacol81292298201210.1124/mol.111.07616622172575
|